Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-20

Clinical Trial Update: A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of 20 mg ambroxol hydrochloride on acute cough has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambroxol hydrochloride (Ambroxol)

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Cough | Phase 2 | Status: COMPLETED